Trial Profile
A Study Assessing the Effect of Anti-Platelet Treatment of Ticagrelor in High-Risk Coronary Patients with Low Response to Clopidogrel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms MATTIS
- 04 Aug 2017 New trial record